
	Three Months Ended June 30,					Six Months Ended June 30,
	2026		2025			2026			2025
Basic Earnings Per Share:
Numerator:
Net income (loss)	$	4,581	$	(19,855	)	$	(15,332	)	$	12,827
Income (loss) attributable to common stockholders - basic	$	4,581	$	(19,855	)	$	(15,332	)	$	12,827

Denominator:
Weighted-average shares outstanding - basic		9,706,193		8,743,733			9,644,704			8,723,589
Net income (loss) per share attributable to common stockholders - basic	$	0.47	$	(2.27	)	$	(1.59	)	$	1.47

Diluted Earnings Per Share:
Numerator:
Net income (loss)	$	4,581	$	(19,855	)	$	(15,332	)	$	12,827
Income (loss) attributable to common stockholders - diluted	$	4,581	$	(19,855	)	$	(15,332	)	$	12,827

Denominator:
Weighted-average shares outstanding - basic		9,706,193		8,743,733			9,644,704			8,723,589

Dilutive impact from:
Stock options to purchase common stock		—		—			—			—
Unvested restricted stock units		40,945		—			—			8,586
Shares issuable under employee stock purchase plan		—		—			—			1
Weighted-average shares outstanding - diluted		9,747,138		8,743,733			9,644,704			8,732,176
Net income (loss) per share applicable to common stockholders - diluted	$	0.47	$	(2.27	)	$	(1.59	)	$	1.47
Anti-dilutive potential common stock equivalents excluded from the calculation of net income (loss) per share:
Stock options to purchase common stock		1,548,690		1,200,467			1,548,690			1,200,467
Unvested restricted stock units		161,748		51,199			161,748			51,199
Shares issuable under employee stock purchase plan		1,464		19,991			922			12,701
Warrants to purchase common stock		32,379		32,379			32,379			32,379

The Company’s potential dilutive securities include stock options, unvested restricted common stock and shares issuable under the 2015 Employee Stock Purchase Plan. The effect of dilutive securities was calculated using the treasury stock method. The anti-dilutive potential common stock equivalents for the six months ended June 30, 2026 and the three months ended June 30, 2025 were excluded from the computation of diluted net loss per share attributable to common stockholders because those stock options to purchase common stock, restricted stock units, and shares issuable under employee stock purchase plan had an anti-dilutive impact as the Company reported a net loss from continuing operations attributable to common stockholders for those periods. The anti-dilutive potential common stock equivalents for the three months ended June 30, 2026 and the six months ended June 30, 2025 were excluded from the computation of diluted net income per share attributable to common stockholders because those stock options to purchase common stock and restricted stock units had an anti-dilutive impact due to the assumed proceeds per share using the treasury stock method being greater than the average fair value of the Company’s common shares for those periods. For that same period, the warrants to purchase common stock were excluded because the exercise price of the Tranche A Warrants is greater than the average fair value of the Company’s common shares.